These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4089810)

  • 1. The effect of lanosterol on platelet aggregation in human platelets.
    Hassall DG; Bruckdorfer KR; Sulpice JC; Lutton C
    Thromb Haemost; 1985 Dec; 54(4):760-3. PubMed ID: 4089810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered properties of platelet membrane in childhood obesity.
    Tangorra A; Ferretti G; Curatola G; Guerrieri A; Catassi C; Giorgi PL; Bertoli E
    Biochem Int; 1988 Nov; 17(5):837-46. PubMed ID: 3254162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased aggregation and secretion responses of human platelets when loaded with the calcium fluorescent probes quin2 and fura-2.
    Lanza F; Beretz A; Kubina M; Cazenave JP
    Thromb Haemost; 1987 Aug; 58(2):737-43. PubMed ID: 3672425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased platelet membrane fluidity due to glycation or acetylation of membrane proteins.
    Winocour PD; Watala C; Perry DW; Kinlough-Rathbone RL
    Thromb Haemost; 1992 Nov; 68(5):577-82. PubMed ID: 1455404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of thrombin-induced platelet aggregation to inhibition by ethanol.
    Marumo M; Wakabayashi I
    Clin Chim Acta; 2009 Apr; 402(1-2):156-9. PubMed ID: 19168042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism involved in the antiplatelet activity of naloxone in human platelets.
    Sheu JR; Hung WC; Lee LW; Chang PT; Kan YC; Yen MH
    Biochem Biophys Res Commun; 1997 Feb; 231(1):12-6. PubMed ID: 9070210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet membrane fluidity and intraplatelet Ca2+ homeostasis are affected in uremia.
    Walkowiak B; Koziołkiewicz W; Michalec L; Borkowska E; Cierniewski CS
    Pol J Pharmacol; 1996; 48(3):299-302. PubMed ID: 9112666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of activators and inhibitors on human blood platelets: study by freeze-fracturing technique and electron microscopy.
    Ariad S; Dvilansky A; Nathan I
    Int J Tissue React; 1984; 6(4):311-5. PubMed ID: 6441789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin interaction with human platelets. Potentiation of thrombin-induced aggregation and release by inactivated thrombin.
    Phillips DR
    Thromb Diath Haemorrh; 1974 Sep; 32(1):207-15. PubMed ID: 4454040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory mechanisms of activated matrix metalloproteinase-9 on platelet activation.
    Lee YM; Lee JJ; Shen MY; Hsiao G; Sheu JR
    Eur J Pharmacol; 2006 May; 537(1-3):52-8. PubMed ID: 16624282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-destabilizing properties of C2-ceramide may be responsible for its ability to inhibit platelet aggregation.
    Simon CG; Gear AR
    Biochemistry; 1998 Feb; 37(7):2059-69. PubMed ID: 9485333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
    Viisoreanu D; Gear A
    Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Releasing growth factors from activated human platelets after chitosan stimulation: a possible bio-material for platelet-rich plasma preparation.
    Shen EC; Chou TC; Gau CH; Tu HP; Chen YT; Fu E
    Clin Oral Implants Res; 2006 Oct; 17(5):572-8. PubMed ID: 16958699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral contraceptives, or lanosterol, on ADP-induced aggregation and binding of 125I-fibrinogen to rat platelets.
    McGregor L; Toor B; McGregor JL; Renaud S; Clemetson KJ
    Thromb Res; 1984 Mar; 33(5):517-22. PubMed ID: 6719398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Difference in inhibitory actions of products of the myeloperoxidase- catalyzed reaction on initial aggregation of activated platelets].
    Rpshchupkin DI; Berzhitskaia VV; Murina MA
    Biofizika; 1998; 43(2):323-8. PubMed ID: 9591107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
    Chen R; Liang N
    Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin receptor occupancy modulates aggregation efficiency and platelet surface expression of vWF and thrombospondin at low thrombin concentrations.
    Kasirer-Friede A; Legrand C; Frojmovic MM
    Thromb Haemost; 1999 Jun; 81(6):967-75. PubMed ID: 10404777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin.
    McNicol A; Robson CA
    J Pharmacol Exp Ther; 1997 May; 281(2):861-7. PubMed ID: 9152395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.